Breaking News

DS Healthcare Signs Long-Term Supply Pact

By Kristin Brooks | February 10, 2014

To provide formulation, ingredients and technology for a topical product

DS Healthcare Group has signed an agreement with a global healthcare company to provide the formulation, ingredients and its technology for use in a topical product. The product when launched will be distributed by the global healthcare company under their own brand following successful development. DS Healthcare will act as the exclusive ingredient supplier for five years, which will automatically renew under certain conditions.
 
"This agreement with a leader in the global healthcare market is a clear indication of the strength of our innovation. DS Healthcare has built a reputation of excellence for our products that has led to this agreement. This is an exciting project that we believe will reach new milestones for us," said DS Healthcare president and chief executive officer Daniel Khesin.

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016